spacer
spacer
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase/hydrolase inhibitor PDB id
1f9e
Jmol
Contents
Protein chains
(+ 0 more) 153 a.a. *
(+ 0 more) 89 a.a. *
Ligands
PHQ-ASP-GLU-VAL-
ASA
×6
Waters ×47
* Residue conservation analysis
PDB id:
1f9e
Name: Hydrolase/hydrolase inhibitor
Title: Caspase-8 specificity probed at subsite s4: crystal structur caspase-8-z-devd-cho
Structure: Caspase-8 alpha chain. Chain: a, c, e, g, i, k. Engineered: yes. Caspase-8 beta chain. Chain: b, d, f, h, j, l. Engineered: yes. (Phq)devd. Chain: q, r, s, t, u, v. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Other_details: chemically synthesized
Biol. unit: Hexamer (from PQS)
Resolution:
2.90Å     R-factor:   0.241     R-free:   0.289
Authors: H.Blanchard,M.Donepudi,M.Tschopp,L.Kodandapani,J.C.Wu,M.G.Gr
Key ref:
H.Blanchard et al. (2000). Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex. J Mol Biol, 302, 9. PubMed id: 10964557 DOI: 10.1006/jmbi.2000.4041
Date:
10-Jul-00     Release date:   10-Jul-01    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q14790  (CASP8_HUMAN) -  Caspase-8
Seq:
Struc:
479 a.a.
153 a.a.*
Protein chains
Pfam   ArchSchema ?
Q14790  (CASP8_HUMAN) -  Caspase-8
Seq:
Struc:
479 a.a.
89 a.a.
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: Chains A, B, C, D, E, F, G, H, I, J, K, L: E.C.3.4.22.61  - Caspase-8.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
 Gene Ontology (GO) functional annotation 
  GO annot!
  Biological process     apoptosis   2 terms 
  Biochemical function     cysteine-type peptidase activity     2 terms  

 

 
DOI no: 10.1006/jmbi.2000.4041 J Mol Biol 302:9 (2000)
PubMed id: 10964557  
 
 
Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex.
H.Blanchard, M.Donepudi, M.Tschopp, L.Kodandapani, J.C.Wu, M.G.Grütter.
 
  ABSTRACT  
 
Caspase-8 is an initiator enzyme in the Fas-mediated pathway of which the downstream executioner caspase-3 is a physiological target. Caspases are cysteine proteases that are specific for substrates with an aspartic acid residue at the P(1) position and have an optimal recognition motif that incorporates four amino acid residues N-terminal to the cleavage site. Caspase-8 has been classified as a group III caspase member because it shows a preference for a small hydrophobic residue at the P(4) substrate position. We report the X-ray crystallographic structure of caspase-8 in complex with benzyloxycarbonyl-Asp-Glu-Val-Asp-aldehyde (Z-DEVD), a specific group II caspase inhibitor. The structure shows that the inhibitor interacts favourably with the enzyme in subsite S(4). Kinetic data reveal that Z-DEVD (K(i) 2 nM) is an almost equally potent inhibitor of caspase-8 as the specific group III inhibitor Boc-IETD-aldehyde (K(i) 1 nM). In view of this finding, the original classification of caspases into three specificity groups needs to be modified, at least for caspase-8, which tolerates small hydrophobic residues as well as the acidic residue Asp in subsite S(4). We propose that the subsite S(3) must be considered as an important specificity-determining factor.
 
  Selected figure(s)  
 
Figure 2.
Figure 2. A diagram of Z-DEVD hydrogen bond interactions with caspase-8. Hydrogen bonds are shown as broken lines. This diagram was produced in ChemDraw.
Figure 3.
Figure 3. Stereoview of the superposition of caspase-8-Z-DEVD onto caspase-8-Z-EVD highlighting the hydrogen bond interaction at subsite S[3]. Superposition was done using the C^a atoms of the conserved subsite S[1] active-site residues Cys285, His237 and Arg341, and was extended for all atoms in a (p18/p12)[2] subunit using LSQMAN [Kleywegt and Jones 1994]. Shown in green is the caspase-8-Z-EVD structure and its hydrogen bond interactions [Blanchard et al 1999]. Caspase-8-Z-DEVD is shown in gold. Both inhibitors are shown in atom colours as ball and stick representations. The structures are depicted as main-chain ball and stick representations with all atoms shown for residues belonging to Loop-1; the hydrogen bond is depicted as dotted spheres and the Figure was produced in Setor [Evans 1993].
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (2000, 302, 9-0) copyright 2000.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21235526 C.Pop, A.Oberst, M.Drag, B.J.Van Raam, S.J.Riedl, D.R.Green, and G.S.Salvesen (2011).
FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity.
  Biochem J, 433, 447-457.  
19851329 N.Keller, M.G.Grütter, and O.Zerbe (2010).
Studies of the molecular mechanism of caspase-8 activation by solution NMR.
  Cell Death Differ, 17, 710-718.  
19283487 B.Fang, G.Fu, J.Agniswamy, R.W.Harrison, and I.T.Weber (2009).
Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling.
  Apoptosis, 14, 741-752.
PDB codes: 3gjq 3gjr 3gjs 3gjt
19278658 N.Keller, J.Mares, O.Zerbe, and M.G.Grütter (2009).
Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation.
  Structure, 17, 438-448.
PDB code: 2k7z
17594508 A.Yoshimori, J.Sakai, S.Sunaga, T.Kobayashi, S.Takahashi, N.Okita, R.Takasawa, and S.Tanuma (2007).
Structural and functional definition of the specificity of a novel caspase-3 inhibitor, Ac-DNLD-CHO.
  BMC Pharmacol, 7, 8.  
17697120 J.Agniswamy, B.Fang, and I.T.Weber (2007).
Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.
  FEBS J, 274, 4752-4765.
PDB codes: 2ql5 2ql7 2ql9 2qlb 2qlf 2qlj
17181147 A.J.Henzing, H.Dodson, J.M.Reid, S.H.Kaufmann, R.L.Baxter, and W.C.Earnshaw (2006).
Synthesis of novel caspase inhibitors for characterization of the active caspase proteome in vitro and in vivo.
  J Med Chem, 49, 7636-7645.  
16801533 C.D.Austin, D.A.Lawrence, A.A.Peden, E.E.Varfolomeev, K.Totpal, A.M.De Mazière, J.Klumperman, D.Arnott, V.Pham, R.H.Scheller, and A.Ashkenazi (2006).
Death-receptor activation halts clathrin-dependent endocytosis.
  Proc Natl Acad Sci U S A, 103, 10283-10288.  
16262685 P.K.Ho, and C.J.Hawkins (2005).
Mammalian initiator apoptotic caspases.
  FEBS J, 272, 5436-5453.  
14645217 C.M.Forsyth, D.Lemongello, D.J.LaCount, P.D.Friesen, and A.J.Fisher (2004).
Crystal structure of an invertebrate caspase.
  J Biol Chem, 279, 7001-7008.
PDB code: 1m72
12920126 A.Schweizer, C.Briand, and M.G.Grutter (2003).
Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway.
  J Biol Chem, 278, 42441-42447.
PDB code: 1pyo
12912912 D.W.Chang, Z.Xing, V.L.Capacio, M.E.Peter, and X.Yang (2003).
Interdimer processing mechanism of procaspase-8 activation.
  EMBO J, 22, 4132-4142.  
12482880 M.Bando, M.Hasegawa, Y.Tsuboi, Y.Miyake, M.Shiina, M.Ito, H.Handa, K.Nagai, and T.Kataoka (2003).
The mycotoxin penicillic acid inhibits Fas ligand-induced apoptosis by blocking self-processing of caspase-8 in death-inducing signaling complex.
  J Biol Chem, 278, 5786-5793.  
12620240 M.Donepudi, A.Mac Sweeney, C.Briand, and M.G.Grütter (2003).
Insights into the regulatory mechanism for caspase-8 activation.
  Mol Cell, 11, 543-549.  
12197899 A.Ueki, Y.Isozaki, A.Tomokuni, T.Hatayama, H.Ueki, M.Kusaka, M.Shiwa, H.Arikuni, T.Takeshita, and K.Morimoto (2002).
Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals.
  Clin Exp Immunol, 129, 556-561.  
11751897 E.L.Meyer, L.C.Gahring, and S.W.Rogers (2002).
Nicotine preconditioning antagonizes activity-dependent caspase proteolysis of a glutamate receptor.
  J Biol Chem, 277, 10869-10875.  
12450324 J.Salgado, A.J.García-Sáez, G.Malet, I.Mingarro, and E.Pérez-Payá (2002).
Peptides in apoptosis research.
  J Pept Sci, 8, 543-560.  
12215447 O.Micheau, M.Thome, P.Schneider, N.Holler, J.Tschopp, D.W.Nicholson, C.Briand, and M.G.Grütter (2002).
The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex.
  J Biol Chem, 277, 45162-45171.  
  11427377 H.Loetscher, O.Niederhauser, J.Kemp, and R.Gill (2001).
Is caspase-3 inhibition a valid therapeutic strategy in cerebral ischemia?
  Drug Discov Today, 6, 671-680.  
11684016 M.Buck, V.Poli, T.Hunter, and M.Chojkier (2001).
C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival.
  Mol Cell, 8, 807-816.  
  11257231 Y.Huang, Y.C.Park, R.L.Rich, D.Segal, D.G.Myszka, and H.Wu (2001).
Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain.
  Cell, 104, 781-790.
PDB code: 1i4o
11114501 M.G.Grütter (2000).
Caspases: key players in programmed cell death.
  Curr Opin Struct Biol, 10, 649-655.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.